Regulation of the pathological vasculature of malignant astrocytomas by angiopoietin-1.
暂无分享,去创建一个
P. Shannon | G. Zadeh | A. Guha | R. Reti | Keyvan Koushan | Qian Baoping
[1] A. Gregory Sorensen,et al. Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.
[2] P. Shannon,et al. Role of Ang1 and Its Interaction with VEGF‐A in Astrocytomas , 2004, Journal of neuropathology and experimental neurology.
[3] G. Zadeh,et al. Targeting the Tie2/Tek receptor in astrocytomas. , 2004, The American journal of pathology.
[4] P. Wesseling,et al. Angiogenesis in brain tumors; pathobiological and clinical aspects , 1997, Journal of Neuro-Oncology.
[5] Daniel J. Dumont,et al. Tek/Tie2 Signaling: New and Old Partners , 2004, Cancer and Metastasis Reviews.
[6] G. Zadeh,et al. Angiogenesis in Nervous System Disorders , 2003, Neurosurgery.
[7] Gelareh Zadeh,et al. Molecular regulators of angiogenesis in the developing nervous system and adult brain tumors (review). , 2003, International journal of oncology.
[8] Johannes Vogel,et al. Heterologous Expression of Human VEGF165 in Rat Brain: Dose-Dependent, Heterogeneous Effects on CBF in Relation to Vascular Density and Cross-Sectional Area , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] G. Zadeh,et al. Neoangiogenesis in human astrocytomas: expression and functional role of angiopoietins and their cognate receptors. , 2003, Frontiers in bioscience : a journal and virtual library.
[10] D. Dumont,et al. The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. , 2002, Seminars in cell & developmental biology.
[11] L. Ellis,et al. Differential expression of angiopoietin‐1 and angiopoietin‐2 in colon carcinoma , 2001, Cancer.
[12] T. Suda,et al. Role for Angiogenesis Expression of Angiopoietin-2 in Human Glioma Cells and Its Updated Version , 2001 .
[13] M. Mrksich,et al. Direct Cell Adhesion to the Angiopoietins Mediated by Integrins* , 2001, The Journal of Biological Chemistry.
[14] F. Lang,et al. Conditional gene expression in human intracranial xenograft tumors. , 2001, BioTechniques.
[15] D. Schiffer,et al. Expression of Angiopoietin-1 in Human Glioblastomas Regulates Tumor-Induced Angiogenesis: In Vivo and In Vitro Studies , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[16] S. Kitano,et al. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. , 2001, Cancer research.
[17] Erwin G. Van Meir,et al. Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. , 2001, The American journal of pathology.
[18] E. Manseau,et al. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. , 2001, The American journal of pathology.
[19] I. Stamenkovic,et al. Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. , 2001, The American journal of pathology.
[20] T. Acker,et al. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor‐2 dominant‐negative receptor mutants , 2001, International journal of cancer.
[21] P. Shannon,et al. Expression and hypoxic regulation of angiopoietins in human astrocytomas. , 2001, Neuro-oncology.
[22] S. McLeskey,et al. Expression and function of angiopoietin-1 in breast cancer , 2000, British Journal of Cancer.
[23] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[24] Ji-Hye Kim,et al. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway , 2000, Oncogene.
[25] Stanley J. Wiegand,et al. Vascular-specific growth factors and blood vessel formation , 2000, Nature.
[26] R. Weksberg,et al. Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence. , 2000, The American journal of pathology.
[27] G. Koh,et al. Characterization and Expression of a Novel Alternatively Spliced Human Angiopoietin-2* , 2000, The Journal of Biological Chemistry.
[28] S. Karpatkin,et al. Identification of a family of alternatively spliced mRNA species of angiopoietin-1. , 2000, Blood.
[29] J. Kim,et al. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. , 2000, Circulation research.
[30] Thomas N. Sato,et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.
[31] G. Yancopoulos,et al. In Situ Expression of Angiopoietins in Astrocytomas Identifies Angiopoietin-2 as an Early Marker of Tumor Angiogenesis , 1999, Experimental Neurology.
[32] G. Yancopoulos,et al. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF , 1999, Oncogene.
[33] G. Yancopoulos,et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.
[34] G. Koh,et al. Angiopoietin‐1 is an apoptosis survival factor for endothelial cells , 1999, FEBS letters.
[35] K. Plate,et al. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. , 1998, The American journal of pathology.
[36] Thomas N. Sato,et al. Increased vascularization in mice overexpressing angiopoietin-1. , 1998, Science.
[37] P. Carmeliet,et al. Insights in Vessel Development and Vascular Disorders Using Targeted Inactivation and Transfer of Vascular Endothelial Growth Factor, the Tissue Factor Receptor, and the Plasminogen System , 1997, Annals of the New York Academy of Sciences.
[38] J. Chason,et al. Surgical Pathology of the Nervous System and Its Coverings , 1983 .
[39] R. Anderson,et al. Surgical Pathology of the Nervous System and Its Coverings , 1977 .